| Dr Larry Phillip Davis, MD | |
|
415 6th St, Lewiston, ID 83501-2431 | |
| (208) 743-2511 | |
| Not Available |
| Full Name | Dr Larry Phillip Davis |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 415 6th St, Lewiston, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720104862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | M5540 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Larry Phillip Davis, MD 415 6th St, Lewiston, ID 83501-2431 Ph: (208) 743-2511 | Dr Larry Phillip Davis, MD 415 6th St, Lewiston, ID 83501-2431 Ph: (208) 743-2511 |
News Archive
PsiOxus Therapeutics, Ltd. announced initiation of a Phase II study of MT-102, a small molecule therapeutic for the treatment of cancer- and age-related wasting. MT-102 is being developed to reverse the effects of cachexia, a wasting disease that accompanies cancer, heart failure, COPD, renal failure, cirrhosis and rheumatoid arthritis, and that is associated with significant morbidity and mortality.
With the coldest months of the year upon us, it's only a matter of time until the first snowfall of the season hits. Sledding, a seasonal favorite for children of all ages seeking thrills, is probably high on kids' to-do lists as the first flakes hit the ground.
Nanomedicine researchers at the Methodist Neurological Institute and Rice University have developed a way to selectively kill brain cancer cells by using a tiny syringe to deliver a combination of chemotherapy drugs directly into the cells. These findings will be published in the April 24 issue of the American Chemical Society journal ACS Nano.
The malaria parasite is particularly pernicious since it is built to develop resistance to treatments. The lack of new therapeutic approaches also contributes to the persistence of this global scourge.
Texas Children's Hospital and SynCardia Systems, Inc. announced today that Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial Heart. The hospital intends to use the Total Artificial Heart as a bridge to transplant for their patients who received a heart transplant as children and now require mechanical support as a bridge to their second transplant.
› Verified 8 days ago
Dr. Thomas Richard Boubel, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 415 6th St, Lewiston, ID 83501 Phone: 208-743-2511 | |
Dr. Edward Angus Vivian, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 415 6th St, Lewiston, ID 83501 Phone: 208-743-2511 | |
Dr. Frank F Ditto, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 415 6th St, Lewiston, ID 83501 Phone: 208-743-2511 |